Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial

Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial

Background In patients with a minor ischaemic stroke or transient ischaemic attack (TIA), separate trials have shown that dual antiplatelet therapy with clopidogrel plus aspirin (clopidogrel–aspirin) or ticagrelor plus aspirin (ticagrelor–aspirin) are more effective than aspirin alone in stroke seco...

Full description

Bibliographic Details
Main Authors: Anding Xu, Yongjun Wang, Yilong Wang, Qiang Dong, Zixiao Li, Xingquan Zhao, Jing Jing, Philip M Bath, Hao Li, Xia Meng, Anxin Wang, Yuesong Pan, Xuewei Xie, Claiborne Johnston
Format: Article
Language:English
Published: BMJ Publishing Group
Series:Stroke and Vascular Neurology
Online Access:https://svn.bmj.com/content/early/2021/05/05/svn-2020-000791.full

Internet

https://svn.bmj.com/content/early/2021/05/05/svn-2020-000791.full

Similar Items